These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11432901)

  • 21. High incidence of brain metastases with trastuzumab treatment.
    Burton A
    Lancet Oncol; 2004 Sep; 5(9):523. PubMed ID: 15384215
    [No Abstract]   [Full Text] [Related]  

  • 22. Cerebral metastases in patients with advanced breast cancer treated with trastuzumab.
    Atkinson J; Peace J; Crawford SM
    Am J Clin Oncol; 2004 Apr; 27(2):212. PubMed ID: 15057165
    [No Abstract]   [Full Text] [Related]  

  • 23. Trastuzumab in CNS progressive metastatic breast cancer.
    Tosoni A; Franceschi E; Esposti RD; Brandes AA
    Future Oncol; 2007 Aug; 3(4):367-9. PubMed ID: 17661709
    [No Abstract]   [Full Text] [Related]  

  • 24. HER2 in brain metastases: issues of concordance, survival, and treatment.
    Fuchs IB; Loebbecke M; Buhler H; Stoltenburg-Didinger G; Heine B; Lichtenegger W; Schaller G
    J Clin Oncol; 2002 Oct; 20(19):4130-3. PubMed ID: 12351617
    [No Abstract]   [Full Text] [Related]  

  • 25. Erlotinib for Progressive Brain and Leptomeningeal Metastases From HER2-positive Breast Cancer After Treatment Failure With Trastuzumab and Lapatinib: Experience and Review of Literature.
    Ji G; Zhang C; Guan S; Yao X
    Clin Breast Cancer; 2018 Oct; 18(5):e759-e765. PubMed ID: 30177482
    [No Abstract]   [Full Text] [Related]  

  • 26. Intrathecal trastuzumab and thiotepa for leptomeningeal spread of breast cancer.
    Ferrario C; Davidson A; Bouganim N; Aloyz R; Panasci LC
    Ann Oncol; 2009 Apr; 20(4):792-5. PubMed ID: 19223574
    [No Abstract]   [Full Text] [Related]  

  • 27. Brain metastases in patients receiving trastuzumab for breast cancer.
    Salmaggi A; Silvani A; Boiardi A
    Neurol Sci; 2007 Mar; 28(1):1. PubMed ID: 17385088
    [No Abstract]   [Full Text] [Related]  

  • 28. Comment on: incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab.
    Errante D; Bernardi D; Bianco A; Salvagno L
    Acta Oncol; 2007; 46(4):565-6. PubMed ID: 17497328
    [No Abstract]   [Full Text] [Related]  

  • 29. [Systemic therapy of cerebral metastases in breast carcinoma].
    Kreuser ED; Herrmann R; Krauseneck P; Mende S; Thiel E
    Dtsch Med Wochenschr; 1991 Aug; 116(31-32):1203-7. PubMed ID: 1860424
    [No Abstract]   [Full Text] [Related]  

  • 30. Brain metastases in patients receiving trastuzumab for breast cancer.
    Errante D; Bernardi D; Bianco A; Salvagno L
    Neurol Sci; 2007 Mar; 28(1):52-3. PubMed ID: 17385098
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine: a case report.
    Shigekawa T; Takeuchi H; Misumi M; Matsuura K; Sano H; Fujiuchi N; Okubo K; Osaki A; Aogi K; Saeki T
    Breast Cancer; 2009; 16(1):88-92. PubMed ID: 18478315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of intracerebral microinfusion of trastuzumab in an athymic rat model of intracerebral metastatic breast cancer.
    Grossi PM; Ochiai H; Archer GE; McLendon RE; Zalutsky MR; Friedman AH; Friedman HS; Bigner DD; Sampson JH
    Clin Cancer Res; 2003 Nov; 9(15):5514-20. PubMed ID: 14654531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Trastuzumab emtansine in the systemic treatment of HER-2-positive breast cancer brain metastases].
    Frenel JS; Bally O; Bourbouloux E; Berton-Rigaud D; Campone M; Bachelot T; Heudel PÉ
    Bull Cancer; 2016 May; 103(5):507-10. PubMed ID: 26992855
    [No Abstract]   [Full Text] [Related]  

  • 34. Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab.
    Yau T; Swanton C; Chua S; Sue A; Walsh G; Rostom A; Johnston SR; O'Brien ME; Smith IE
    Acta Oncol; 2006; 45(2):196-201. PubMed ID: 16546866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Trastuzumab in metastatic breast carcinoma].
    Susnjar S; Bosnjak S; Radulovic S
    Srp Arh Celok Lek; 2001; 129(5-6):147-52. PubMed ID: 11797464
    [No Abstract]   [Full Text] [Related]  

  • 36. Systemic treatment of brain metastases in HER2-positive breast cancer: current status and future directions.
    Azim HA; Azim HA
    Future Oncol; 2012 Feb; 8(2):135-44. PubMed ID: 22335578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The requirements to clinicopathology about targeted therapy for breast cancer].
    Jiang ZF; Shen G
    Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):435-7. PubMed ID: 17845752
    [No Abstract]   [Full Text] [Related]  

  • 38. [A case of advanced breast cancer with meningeal carcinomas and orbital metastasis successfully treated with multi-disciplinary therapy].
    Sakurai K; Amano S; Enomoto K; Matsuo S
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1913-5. PubMed ID: 17212145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of patients with brain metastases receiving trastuzumab treatment for metastatic breast cancer.
    Witzel I; Kantelhardt EJ; Milde-Langosch K; Ihnen M; Zeitz J; Harbeck N; Jänicke F; Müller V
    Onkologie; 2011; 34(6):304-8. PubMed ID: 21625183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biotherapy of cancer marches on!
    DeNardo GL
    Cancer Biother Radiopharm; 1998 Oct; 13(5):335-6. PubMed ID: 10851423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.